At a glance
ClinicalIndex Comparison RecordN/ACompleted· 9 enrolled
Drug / intervention
BioCleanse Meniscusother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Application of BioCleanse Meniscus Registry
In Brief
An observational study evaluating BioCleanse Meniscus for Tear of Meniscus of Knee. Completed, enrolled 9 participants across 1 site.
Detailed Summary
This study will follow patients after routine surgery of a meniscal allograft transplant.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsTear of Meniscus of Knee
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartApr 2008
First PostedApr 2008
Primary CompletionJul 2015
TodayJul 2026
First PostedApr 16, 2008
Enrollment StartApr 1, 2008
Primary CompletionJul 1, 2015
TodayJul 2, 2026
Enrollment to primary: 7.3 yearsPosted 18.2 years ago
Interventions
BioCleanse Meniscusother
Subjects will undergo routine meniscal allograft transplant surgery.